Briefing Information for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
FDA Briefing Information, Progression-Free Survival in Non-Hematologic Malignancies, for the July 24, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 186KB)